![Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu](https://image.isu.pub/220523125456-31254084c0fc681ef531a9580454bbd7/jpg/page_1.jpg)
Guidelines for the Management of Transfusion-Dependent Thalassaemia (4th Edition - Version 2.0) by Thalassaemia International Federation (TIF) - Issuu
![Current status of beta‐thalassemia and its treatment strategies - Ali - 2021 - Molecular Genetics & Genomic Medicine - Wiley Online Library Current status of beta‐thalassemia and its treatment strategies - Ali - 2021 - Molecular Genetics & Genomic Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/1abbbfe5-56e9-4966-a36b-5232139cf212/mgg31788-fig-0005-m.jpg)
Current status of beta‐thalassemia and its treatment strategies - Ali - 2021 - Molecular Genetics & Genomic Medicine - Wiley Online Library
![A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy - ScienceDirect A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2473952921000744-gr2.jpg)
A systematic review of quality of life in sickle cell disease and thalassemia after stem cell transplant or gene therapy - ScienceDirect
![Cureus | Blood Demand and Challenges for Patients With Beta-Thalassemia Major in Eastern Saudi Arabia | Article Cureus | Blood Demand and Challenges for Patients With Beta-Thalassemia Major in Eastern Saudi Arabia | Article](https://assets.cureus.com/uploads/figure/file/245562/lightbox_8acfee30f26a11eb908c39c985c12dca-fig.1.png)
Cureus | Blood Demand and Challenges for Patients With Beta-Thalassemia Major in Eastern Saudi Arabia | Article
Cure for thalassemia major – from allogeneic hematopoietic stem cell transplantation to gene therapy | Haematologica
![Frontiers | The Future of Gene Therapy for Transfusion-Dependent Beta- Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells Frontiers | The Future of Gene Therapy for Transfusion-Dependent Beta- Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells](https://www.frontiersin.org/files/Articles/730873/fphar-12-730873-HTML/image_m/fphar-12-730873-g001.jpg)
Frontiers | The Future of Gene Therapy for Transfusion-Dependent Beta- Thalassemia: The Power of the Lentiviral Vector for Genetically Modified Hematopoietic Stem Cells
![Current status of beta‐thalassemia and its treatment strategies - Ali - 2021 - Molecular Genetics & Genomic Medicine - Wiley Online Library Current status of beta‐thalassemia and its treatment strategies - Ali - 2021 - Molecular Genetics & Genomic Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/2c1043ea-7266-4058-9af7-69fe784f94c3/mgg31788-fig-0004-m.jpg)
Current status of beta‐thalassemia and its treatment strategies - Ali - 2021 - Molecular Genetics & Genomic Medicine - Wiley Online Library
![Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley](https://onlinelibrary.wiley.com/cms/asset/a3ab599c-f810-44a4-8d26-916b998a40ec/ajh.25584.fp.png)
Quality of life in patients with β‐thalassemia: A prospective study of transfusion‐dependent and non‐transfusion‐dependent patients in Greece, Italy, Lebanon, and Thailand - Cappellini - 2019 - American Journal of Hematology - Wiley
![PDF) Cure for thalassemia major – From allogeneic hematopoietic stem cell transplantation to gene therapy PDF) Cure for thalassemia major – From allogeneic hematopoietic stem cell transplantation to gene therapy](https://i1.rgstatic.net/publication/311339660_Cure_for_thalassemia_major_-_From_allogeneic_hematopoietic_stem_cell_transplantation_to_gene_therapy/links/59b7f5cd0f7e9bd4a7ff1be6/largepreview.png)
PDF) Cure for thalassemia major – From allogeneic hematopoietic stem cell transplantation to gene therapy
Replacing the suppressed hormone: toward a better treatment for iron overload in β-thalassemia major? | Haematologica
![IJMS | Free Full-Text | Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis IJMS | Free Full-Text | Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis](https://pub.mdpi-res.com/ijms/ijms-19-04070/article_deploy/html/images/ijms-19-04070-g001.png?1570835982)
IJMS | Free Full-Text | Hepatocellular Carcinoma in β-Thalassemia Patients: Review of the Literature with Molecular Insight into Liver Carcinogenesis
![IJMS | Free Full-Text | Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia IJMS | Free Full-Text | Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia](https://www.mdpi.com/ijms/ijms-18-02778/article_deploy/html/images/ijms-18-02778-g001.png)
IJMS | Free Full-Text | Iron Overload and Chelation Therapy in Non-Transfusion Dependent Thalassemia
![Recent Progress in Gene Therapy and Other Targeted Therapeutic Approaches for Beta Thalassemia | Bentham Science Recent Progress in Gene Therapy and Other Targeted Therapeutic Approaches for Beta Thalassemia | Bentham Science](http://www.eurekaselect.com/images/graphical-abstract/cdt/20/16/001.jpg)
Recent Progress in Gene Therapy and Other Targeted Therapeutic Approaches for Beta Thalassemia | Bentham Science
![Guidelines for the Management of Non-Transfusion Dependent Thalassaemias (2nd edition - 2017) by Thalassaemia International Federation (TIF) - Issuu Guidelines for the Management of Non-Transfusion Dependent Thalassaemias (2nd edition - 2017) by Thalassaemia International Federation (TIF) - Issuu](https://image.isu.pub/190625083856-41aa3feae0925fdc76612629c95e50f8/jpg/page_1.jpg)
Guidelines for the Management of Non-Transfusion Dependent Thalassaemias (2nd edition - 2017) by Thalassaemia International Federation (TIF) - Issuu
![Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia](https://www.mdpi.com/biomolecules/biomolecules-11-00755/article_deploy/html/images/biomolecules-11-00755-g001.png)
Biomolecules | Free Full-Text | Epigenetic Insights and Potential Modifiers as Therapeutic Targets in β–Thalassemia
![Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis](https://www.mdpi.com/diseases/diseases-10-00085/article_deploy/html/images/diseases-10-00085-g001.png)
Diseases | Free Full-Text | Luspatercept: A New Tool for the Treatment of Anemia Related to β-Thalassemia, Myelodysplastic Syndromes and Primary Myelofibrosis
![A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? - ScienceDirect A paradigm shift on beta-thalassaemia treatment: How will we manage this old disease with new therapies? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0268960X17301303-gr1.jpg)